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of current testing practice
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Abstract
Background: We have shown previously that current recommendations in UK guidelines for monitoring long-term
conditions are largely based on expert opinion. Due to a lack of robust evidence on optimal monitoring strategies
and testing intervals, the guidelines are unclear and incomplete. This uncertainty may underly variation in testing
that has been observed across the UK between GP practices and regions.
Methods: Our objective was to audit current testing practices of GPs in the UK; in particular, perspectives on
laboratory tests for monitoring long-term conditions, the workload, and how confident GPs are in ordering and
interpreting these tests. We designed an online survey consisting of multiple-choice and open-ended questions
that was promoted on social media and in newsletters targeting GPs practicing in UK. The survey was live between
October–November 2019. The results were analysed using a mixed-methods approach.
Results: The survey was completed by 550 GPs, of whom 69% had more than 10 years of experience. The majority
spent more than 30 min per day on testing (78%), but only half of the respondents felt confident in dealing with
abnormal results (53%). There was a high level of disagreement for whether liver function tests and full blood
counts should be done ‘routinely’, ‘sometimes’, or ‘never’ in patients with a certain long-term condition.
The free text comments revealed three common themes: (1) pressures that promote over-testing, i.e. guidelines or
protocols, workload from secondary care, fear of missing something, patient expectations; (2) negative
consequences of over-testing, i.e. increased workload and patient harm; and (3) uncertainties due to lack of
evidence and unclear guidelines.
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Conclusion: These results confirm the variation that has been observed in test ordering data. The results also show
that most GPs spent a significant part of their day ordering and interpreting monitoring tests. The lack of
confidence in knowing how to act on abnormal test results underlines the urgent need for robust evidence on
optimal testing and the development of clear and unambiguous testing recommendations. Uncertainties
surrounding optimal testing has resulted in an over-use of tests, which leads to a waste of resources, increased GP
workload and potential patient harm.
Keywords: General practice, Optimal testing, Chronic disease monitoring
Background
The number of tests ordered by GPs has tripled over the
last 20 years [1]. One of the reasons for this increase is a
growing ageing population with complex health needs.
In addition, over the last 20 years, many secondary care
services have been diverted to primary care [2]. The
Quality and Outcomes Framework, which was intro-
duced on 1 April 2004, incentivises laboratory testing for
long-term conditions and has been associated with an
increase in GP consultation rates [3]. Around half of the
diagnostic tests ordered in primary care are for monitor-
ing long-term conditions [4]. However, routine testing is
supported by limited evidence and much of it may be
unnecessary.
The over-use of tests has contributed to increased
NHS spending and an ever-rising GP workload. UK
primary care spends an estimated £1.8bn per year on
laboratory tests [1]. The total costs are probably higher,
because this figure does not account for the cost of GPs
time reviewing test results or the administration of pro-
cessing testing data. Time spent on reviewing test results
was estimated at 25–35min per day for GPs in 2000/1
and increased to 1.5–2 h per day in 2015/16 [1]. Typical
working days for GPs are currently between 10 and 14 h
long [5]. Over-testing also increases the risk of false
positive test results, which can cause anxiety for patients
and unnecessary additional GP appointments, phlebot-
omy or medical imaging (i.e. ultrasound, X-ray, CT scan,
MRI) appointments, and referrals – risking avoidable
harm to patients [6–8].
To reduce healthcare costs, efforts have been made to
identify unwarranted variation in testing. Geographical
variation in testing is unwarranted when it cannot be ex-
plained by variation in population needs. There is substan-
tial variation in test ordering across the UK between GP
practices and regions [9]. A recent systematic review of
UK guidelines shows that current recommendations for
monitoring hypertension, type 2 diabetes, and chronic kid-
ney disease (CKD) are largely based on expert opinion
[10]. Due to a lack of robust research evidence on optimal
monitoring strategies and testing intervals, the guidelines
are unclear and incomplete [10]. This uncertainty may
underlie unwarranted variation in testing.
To audit current testing practices of GPs in the UK,
we developed a questionnaire-based survey that was sent
out to GPs across the UK. The main focus of the audit
was on GP perspectives on laboratory tests in monitor-
ing long-term conditions, workload involved in testing,




The survey was developed by academics and GPs with a
special interest in optimal testing for long-term condi-
tions in primary care using OnlineSurveys, an online
survey tool designed for academic research. OnlineSur-
veys use an ISO 27001 certified information security
management system [11] and comply with the General
Data Protection Regulation [12]. Survey questions were
piloted in the GP practices of the co-authors and
amongst GPs of the Optimal Testing Group, a subgroup
of the Royal College of General Practitioners (RCGP)
Overdiagnosis group [13].
Survey dissemination
The survey was available from any computer or mobile
device at any time between 7 October and 30 November
2019. The survey was endorsed by the RCGP who
helped promote the survey in their newsletter and clin-
ical news article. In addition, the survey was dissemi-
nated via the national GP research network practices
(PCRN), doctors.net forum, and social media. All GP
practising in the UK were eligible to fill out the survey.
Survey questions
The survey consisted of 14 multiple-choice questions
and one free-text question. Most multiple-choice ques-
tions included an ‘other’ option, which individuals could
specify. Three questions were on demographics (sex, lo-
cation, years since qualification). Nine questions covered
workload, confidence in underlying evidence and how to
deal with abnormal test results, perspectives on the
number of tests being done, importance of research in
optimal testing, and risk of patients harm due to over-
testing, processes that determine which tests are being
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done, and how often tests are done for secondary care.
The final multiple-choice question was optional and
asked which tests the GPs perform routinely, sometimes,
or never, for an average adult patient with hypertension,
type 2 diabetes, or CKD. At the end of the survey,
individuals had the opportunity to add any com-
ments or questions about testing in primary care.
See Additional file 1 for the full questionnaire.
Data analysis
We used descriptive statistics (percentages, medians, inter
quartile ranges (IQR)) to describe the quantitative findings
of the survey. The UK has four increasingly distinct
healthcare systems in England, Wales, Northern Ireland,
and Scotland; therefore, we performed a sensitivity ana-
lysis by limiting the analysis to GPs practicing in England.
The analysis was performed in Stata 15.1 [14].
As Question 17 (“which tests do you perform routinely,
sometimes, or never, for an average adult patient with
hypertension, type 2 diabetes, or CKD”) was optional, we
only included respondents in the analysis who fully an-
swered this question. Respondents were asked to select
one of three options (routinely, sometimes, or never) per
test and condition. If respondents selected more than one
option, only the higher frequency option was included in
the analysis (i.e. if both “never” and “sometimes” were se-
lected, it was counted as “sometimes”). However, if both
“never” and “routinely” were selected for the same test in
the same condition, the answer was deemed invalid and
excluded from analysis. We performed an exploratory
analysis to identify significant relationships between the
level of testing and explanatory variables (i.e. sex, region,
workload, level of experience or confidence) using Chi-
squared tests. Levels of testing were categorised as ‘low’,
‘medium’, and ‘high’ according to GPs self-reported testing
behaviour for all three conditions.
To identify patterns and themes within the answers
given to the final free text question, we used an induct-
ive thematic analysis as described by Braun and Clarke
[15], which is a bottom-up approach to explore qualita-
tive data. KA and ME coded the free-text answers and
analysed the responses by identifying higher-level recur-
ring themes and looked for suggested solutions.
Results
Sample demographics
A total of 550 individuals completed the survey (Table 1).
Fifty per cent of respondents identified as male. We re-
ceived responses from all major geographical regions in
the UK, although most GPs (n = 170) were practicing in
the South West of England at the time of completing
the survey. The fewest responses were from Northern
Ireland (n = 3). Most respondents had more than 10
years’ experience as a GP (n = 383) (Table 1).
Tests in primary care: workload, confidence and
perspectives
On their most recent full practice day, 429 (78%) GPs
spent more than 30 min on ordering, interpreting and
acting on laboratory tests for routine monitoring of
long-term conditions (including time for ordering tests,
reviewing test results, talking to patients about the re-
sults and any action resulting from the original test, such
as further testing or referrals). 157 (28.6%) GPs had
spent more than 1 h of this practice day on tests (Fig. 1).
290 (52.8%) GPs felt confident (of which 24 very
confident) in what to do with abnormal incidental find-
ings picked up during long-term disease monitoring and
259 (47%) GPs felt less than confident. 440 (80.4%) GPs
were less than confident that the tests they perform are
evidence-based. 338 (61.7%) GPs believed that further
research on optimising testing in primary care is of high
importance. 478 (87.1%) GPs believed that blood test
monitoring can at least occasionally be harmful to pa-
tients. Many GPs are asked to do tests for secondary
care outside of a shared care agreement – 405 (73.8%)
GPs indicated this happens frequently to very frequently
(Fig. 1). Only 343 (62.7%) were able to download sec-
ondary care blood results into their clinical system.
GPs indicated that they used one or more of the fol-
lowing processes in their practice for deciding which
blood tests to use: a practice protocol (n = 354, 64.4%),
the quality and outcomes framework (n = 254, 46.2%),
Table 1 Sample demographics
n (%)
Sex (male) 279 (50.73)
Region
North West 22 (4.01)
London 44 (8.01)
South West 170 (30.97)
West Midlands 55 (10.02)
South Central 37 (6.74)
South East Coast 18 (3.28)
Scotland 87 (15.85)
East of England 15 (2.73)
Wales 12 (2.19)
Northern Ireland 3 (0.55)
Yorkshire and Humber 19 (3.46)
East Midlands 57 (10.38)




> 10 383 (69.64)
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NICE clinical guidelines (n = 175, 31.8%), and laboratory
electronic test ordering profiles (e.g. ICE profiles in
England) (n = 197, 35.8%) 143 (26%) GPs used bespoke
plans for individual patients and 32 (5.8%) did not know.
We performed a sensitivity analysis to explore the im-
plications of limiting the analysis to the responses from
GPs practicing in England. Excluding responses from
Wales (n = 12), Scotland (n = 89), and Northern Ireland
(n = 3) had limited effect on the results (changing the re-
sponses by no more than 1–2%) and did not affect the
overall trends (Additional file 2).
Tests used for patients with hypertension, type 2
diabetes, and chronic kidney disease.
Fifty-six percent of respondents answered the optional
question on which tests they ordered routinely, some-
times or never for hypertension, type 2 diabetes, and
CKD. The following results are based on their answers
only.
For patients with hypertension, type 2 diabetes, and
CKD, GPs ordered a median of 3 (IQR 2–4), 5 (IQR 4–
6), and 3 (IQR 2–5) tests routinely, respectively. Creatin-
ine, Urea, and Electrolytes was the most common test
that was ordered routinely for all three patient groups
(> 95%). We found a high level of disagreement (i.e. vari-
ation) for a number of tests, where ‘never’, ‘sometimes’,
and ‘routinely’ were selected by an almost equal numbers
of GPs. This was especially the case for liver function tests
(LFTs) and full blood count (FBC) in all three conditions
(Fig. 2). We found little evidence of any pattern that could
explain this level of disagreement (i.e. sex, region, work-
load, level of experience or confidence) (Additional file 3).
Current UK guidelines recommend routine testing of
creatinine, urea, and electrolytes, lipid profile, HbA1c, and
urine albumin to creatinine ratio in patients with hyper-
tension [16–18]. Most GPs (n = 288, 95.4%) routinely or-
dered creatinine, urea, and electrolytes for hypertension;
however, only half or less of the GPs routinely ordered
lipid profile (n = 156, 52.0%), HbA1c (n = 121, 39.9%), or
urine albumin to creatinine ratio (n = 102, 33.7%). Several
tests that are not specifically mentioned by current guide-
lines were done routinely by some GPs, such as FBC (n =
58, 19.3%) and LFTs (n = 79, 26.1%) (Fig. 2a).
For all patients with diabetes, current UK guidelines rec-
ommend routine testing of creatinine, urea, and electro-
lytes [18, 19], urine albumin to creatinine ratio [18, 19],
and HbA1c [20, 21]. These test are performed routinely
by most GPs in our study sample: 99.3% (n = 301), 87.5%
(n = 265), and 99.0% (n = 300), respectively. Although less
clearly mentioned in the NICE and SIGN guidelines [19,
20, 22], the Clinical Knowledge Summaries (CKS) recom-
mend assessing a person’s full lipid profile annually [23],
which was performed routinely by 75.2% (n = 227) of the
GPs. Other tests that GPs selected, which are not men-
tioned by guidelines, were LFTs (n = 173, 57.1%), FBC
(n = 125, 41.3%), and thyroid function tests (n = 69, 22.9%)
(Fig. 2b). New thyroid disease guidelines recommend to
‘not offer testing for thyroid dysfunction solely because an
adult, child or young person has type 2 diabetes’. [24].
Fig. 1 Tests in primary care: workload, confidence and perspectives
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UK guidelines recommend testing creatinine, urea,
and electrolytes [18, 21], and urine albumin to creatinine
ratio [18] at least annually in patients with CKD. These
were done routinely by 99.0% (n = 301) and 77.2% (n =
233), respectively, of the GPs in our sample. NICE CKD
guidelines also recommend to check the haemoglobin
level in people with a GFR of less than 45ml/min/1.73
m2 [18], which was done routinely by 47.5% (n = 144) of
GPs in our sample. A substantial number of GPs also
routinely ordered lipid profile (n = 114, 37.9%) and
HbA1c (n = 68, 22.6%) for the average patient with CKD,
which are not specifically mentioned by current guide-
lines (Fig. 2c).
Common themes in GP comments
Twenty-four per cent of respondents left a comment in
the free text box at the end of the survey. We identified
three overarching themes and 11 sub-themes in these
comments (Table 2), which are discussed below, as well
as solutions suggested by respondents.
Pressures that promote over-testing
GPs identified several pressures that may cause GPs to
order more tests than necessary. Many GPs mentioned
guidelines, practice protocols, and the Quality and Out-
comes Framework (QOF), that promote extra and pos-
sibly unnecessary testing:
“[I] believe [testing] should be for a particular reason
and at a time that is right for the patient and find it
frustrating that 'guidelines' and QOF insist on GPs
doing lots of unnecessary tests.”
GPs feel they have no choice but to follow these proto-
cols, even if they believe a test is not necessary and a
waste of resources. GPs mentioned pressure from
colleagues to adhere to the protocols,
Fig. 2 Test ordering for an average adult patient with a common long-term condition. These graphs show the percentage of GPs that prescribe
certain tests never, sometimes or routinely to patients with hypertension (a), type 2 diabetes (b), or CKD (C). The star (*) indicates tests that are
recommended by current UK guidelines to be done routinely in these patient groups
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“I am under huge pressure from ‘guideline addicts’
in my practice”
or concerns about medico-legal consequences if they
don’t,
“It does not feel safe from a medico-legal point of
view to reduce testing.”
GPs believe extra tests are added out of fear of missing
something and many unnecessary tests are ordered “just
in case” or “to be safe”. One GP wrote:
“I think we work in a defensive way, fearing
litigation or complaints if we miss something.”
GPs are increasingly expected to manage and follow
up tests requested by secondary care. One GP reported,
“[A] huge additional workload from secondary care
redirecting requests to primary care”.
GPs are concerned about the large volume of duplicate
tests and repeat tests in response to slight abnormalities
picked up in secondary care, as well as requests to moni-
tor treatments without clear guidance or to follow up on
test results while it is unclear why that test was requested
in the first place. GPs also mentioned the pressure from
patients themselves, who expect and ask for extra tests:
“[The] main issue is patients requesting tests, not
just 'routine' reviews,” and “I feel under pressure to
request too many [ … ] and am at pains to explain
to patients that results may not give the reassurance
they seek.”
Another reason mentioned for doing more tests than
necessary is to avoid additional future nurse appointments:
“When I try to rationalise tests, something else
happens to the [patient] and I wish I’d just done
the whole raft of tests to save multiple trips for
patients and appointments for us.”
Consequences of over-testing
GPs mentioned several negative consequences of over-
testing, especially the increased workload:
“I am overwhelmed with all the routine monitoring
and it has risen massively over the 20+ years I have
been qualified,”
which is negatively effecting job satisfaction:
“The monitoring of results is sinking the morale of
GPs due to the volume of work.”
A few GPs acknowledged the waste of resources,
“I regard the over-investigation of essentially well pa-
tients on an annual basis as a simply scandalous
waste of NHS resource as well as a frequent source
of trivial results which require further tests!”
and the possible harm unnecessary testing has on patients,
“The harms and distress caused by testing and
explaining minor abnormalities is huge.”
Uncertainty
GPs need to deal with many uncertainties, which com-
plicates optimal monitoring for long-term conditions.
One major problem is the lack of evidence on how,
when, and how often patients should be monitored to
improve their outcomes. One GP explained,
“We have recently updated our long-term condition
protocols and it has been difficult to find evidence-
based literature on how frequently and what type of
blood tests should be ordered routinely for long-term
conditions.”
Some GPs are uncertain about what other staff nurses/
health care assistants are doing in their treatment rooms:
“One of the challenges is that bloods are often
requested by another member of the [multidisciplinary
team] (e.g. [practice nurse] or pharmacist) making it
more difficult and time-consuming to interpret, and
often creating additional workload.”
Many GPs are unaware of the costs associated with
the tests that they order:




Quality and Outcomes Framework
(QOF)/ guidelines/protocol
Workload from secondary care
Fear of missing something
Patient led demand/expectation






Uncertainty Lack of evidence for clinical practice
How frequently to monitor
Doctors being uncertain about what other
staff nurses/healthcare assistants are doing
in their treatment room
Cost of tests
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“We are not given any indication of the costs of tests
(despite asking laboratory) to allow cost-effectiveness
to be considered.”
Suggested solutions
GPs ask for clear guidelines on the optimal frequency of
testing, on when/what not to test to avoid litigation and
complaints, and on what to do with slightly abnormal
test results. The lack of evidence needs to be addressed
and feed into new evidence-based guidelines. Guidelines
need to recommend a minimal testing set and specify
how to personalise testing strategies. GPs said,
“It would be nicer to have a more bespoke approach
with really good evidence base guidelines to help us”,
and
“It would be really good to have a MINIMAL set of
evidence based routine monitoring for these
conditions”.
Several GPs highlighted the issue of having to review
test results that someone else has ordered for unknown
reasons, for instance by secondary care doctors, practice
nurses, or pharmacists. Some GPs believe that the number
of unnecessary test ordering and the workload for GPs to
follow up on results will reduce when test results must be
checked by the person that ordered them. For example,
“Secondary care doctors should be bound to check
their own results, not tell patients to 'see your GP’,”
and
“One of the challenges is that bloods are often re-
quested by another member of the [multidisciplinary
team] [ … ]. The tests should go back to the request-
ing clinician where possible.”
The number of unnecessary tests and follow up testing
can be reduced significantly when duplication of tests
from secondary care are avoided. This can be achieved by
having access to their results and compatible IT systems:
“Lots of tests might be avoided if it was known that
it had been done recently in hospital. Avoiding all
this would save hours of GP time, hours of phlebotomy
time and £££ in the lab, not to mention appointment
staff and clogged up car park,” and
“Large problem is being able to access results from
secondary care - to avoid duplication.”
More awareness is needed among GPs and other staff
involved in test ordering regarding the costs of tests and
the potential patient harm. To achieve this, GPs suggest
the following:
“I think routinely the cost of each test should be next
to it… would a GP just click on the ESR (Educational
Supervisor’s Review) if it was £10 ‘just because’ or
would they pause to consider if their differential
includes GCA (giant cell arteritis) or suspected
Rheum disease?”, and
“Totally agree that unnecessary tests cause distress
and patient anxiety and this needs to be taught at
medical school - how not to follow a protocol and
use clinical judgement.”
Finally, one GP suggested that:
“Patient [s] should be obliged to pay privately for




A considerable part of a GPs working day is filled with
ordering or reviewing tests. Still, only half of the respon-
dents felt confident in dealing with abnormal results.
GPs answers varied substantially on testing frequency
for patients with either hypertension, type 2 diabetes, or
CKD. This was especially true for LFTs and FBC, where
almost equal numbers of GPs indicated they order these
tests ‘routinely’ or ‘never’.
Most GPs routinely ordered tests that are recom-
mended by current UK guidelines for patients with
hypertension, type 2 diabetes, or CKD. Exceptions were
urine albumin to creatinine ratio for CKD and hyperten-
sion patients and HbA1c for hypertension patients,
which are recommended by guidelines but were ordered
‘never’ or ‘sometimes’ by most GPs. In addition, many
GPs perform additional tests on a routine basis that are
not recommended by guidelines, such as lipid profile
and LFTs, although some of these tests may have been
selected because GPs assumed that they need to monitor
for medications in these patient groups. Testing outside
guidelines is de facto screening.
The free text comments revealed three common
themes: (1) pressures that promote over-testing, includ-
ing guidelines or practice protocols, workload from sec-
ondary care, fear of missing something, patient requests
and expectations, (2) negative consequences of over-
testing, such as increased workload and patient harms,
and (3) uncertainties due to lack of evidence and unclear
guidelines, which in itself can be a cause of over-testing.
GPs suggested several solutions, such as better align-
ment with secondary care testing to avoid duplication
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and increasing awareness on costs and harms of testing.
Above all, GPs highlighted the need for clear evidence-
based guidelines.
Strengths and limitations
A strength of this audit is the combination of both quan-
titative and qualitative data and analysis methods. The
open text box allowed GPs to highlight issues in their
own words that were particularly important to them.
These data provided important context for interpreting
the quantitative data. The anonymity of respondents en-
couraged GPs to answer the questions honestly, espe-
cially on questions about confidence and to raise
additional issues in the free text space. It was not pos-
sible to calculate a response rate to the survey, as we do
not know how many GPs were reached through social
media dissemination, however the number of responses
exceeded our sample size calculation.
Limitations included the representativeness of the
sample. The study participants consisted of a self-
selected sample and so, GPs interested in this area of
research or GPs who felt strongly about issues related to
testing were more likely to respond. Therefore, the per-
spectives of the study sample are not necessarily repre-
sentative of all GPs in the UK. Although we received
responses from all areas of the UK and equal numbers
of responses from men and women, there was an over-
representation of GPs practicing in the South-West area,
where our team is based. There was a lack newly quali-
fied GPs among the survey participants, which may have
led to an underestimation of uncertainty and variation in
testing.
Our audit targeted GPs only, although nurses, health-
care assistants, and pharmacists also play a role in test
ordering. The number of non-GP clinicians in primary
care is rising [25] and some evidence suggests that this
is linked to an increased use of tests [26]. Thus, a major
limitation of this study is that this group of individuals
was not included.
Comparison with existing literature
Our findings chime with previous work that showed
large geographical variation in test ordering behaviour
among GPs [1, 9]. These studies used routinely collected
primary care data, which do not contain data on the GPs
reasons for testing. In contrast, our survey highlights
which tests GPs order for an average adult patient to
monitor a specific long-term condition. To our know-
ledge, this is the first study that shows the variation in
GP test ordering behaviour for the same fictional ‘aver-
age adult patient’.
GPs selected a number of additional tests that are not
recommended by UK guidelines. A review of testing
panels used for monitoring long-term conditions among
20 GP practices in North Devon found that no two prac-
tices recommended the same set of tests [27]. We sus-
pect that much of the additional testing is the result of
local practice protocols. Most practices in North Devon
included regular LFTs and FBC in their chronic disease
monitoring protocols [27]. We found large variation in
the use of these two tests in our study sample. Our
results suggest that routine testing for LFT and FBC
occurs UK-wide, despite the fact that these tests are not
recommended by national guidelines.
Implications for research and practice
Although guidelines lack a strong evidence base, they
represent best current practice. However, current guide-
lines are often unclear about frequency of testing and
testing recommendation for long-term conditions are
spread over several different documents [10]. Because
there are no clear national testing protocols to follow,
GP practices develop and use their own. New primary
care-based guidelines are needed that specifically inform
the use of tests in monitoring long-term conditions. In
absence of clear evidence, the use of minimal testing sets
with longer testing intervals should be encouraged.
Efforts should be made to align local practice protocols
with these new testing guidelines. Reducing unnecessary
testing has been suggested as an important priority to
help ensure value-based primary care [28]. In North
Devon, a quality improvement project that set out to
‘standardise the blood tests used for monitoring of
chronic conditions in primary care’ resulted in a 14% re-
duction for FBC testing and a 22% reduction for LFTs,
without reducing the number of tests showing possible
significant pathology [27]. Our survey and the North
Devon review suggest that aligning local practice proto-
cols can reduce unnecessary testing without a reduction
in detection rate for significant abnormality. These
guidelines should also protect GPs from complaints and
litigation when patients demand additional (and poten-
tially unnecessary) tests.
Increasing awareness of costs related to testing among
GPs, practice nurses, and healthcare assistants will en-
able them to incorporate costs into their decision-
making. In addition, primary care clinicians need to be
aware of patient harms caused by over-testing. The risk
of false positive results is high in a low prevalence set-
ting such as primary care, especially for tests that have
been ordered without clear indication or rationale. GPs
should consider offering training to nursing staff or
healthcare assistants who are involved in test ordering
about the potential harms of over-testing. Openly shar-
ing uncertainty and fallibility regarding diagnostic tests
with patients and colleagues has been suggested as a
promising strategy to prevent the harm of over-testing
[29]. Although shared-decision making is widely accepted
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as best practice, most research has focused on treatment
decisions rather than investigations. Sharing uncertainty
to help facilitate shared decision making can be challen-
ging in clinical practice – patient and doctors have
been shown to have limited understanding of health
statistics and risk [30], and tend to overestimate the
benefits of tests [31].
GPs should be able to access test results from second-
ary care to avoid duplication. Only 63% of GPs in our
sample was able to do this. This should be a priority for
the NHS because precious resources are being wasted
due to inefficient communication and incompatible IT
systems between primary and secondary care.
Conclusion
In order to improve guidelines, we need strong evidence
on what testing strategies inform patient care and im-
prove patient outcomes. One of the main problems with
current guidelines is that they promote more care (pre-
scribe more, intervene more, refer more) rather than less
[32, 33]. Although implementation of evidence-based
guidelines can improve patient care and outcomes [34],
they do not reduce the workload of the clinicians. Also,
there is a reluctance to take out recommendations of
existing guidelines as long as they do not cause harm,
even if new evidence suggest there is no clear benefit
[34]. To reduce stress and workload, we need to identify
routine services that can be stopped or scaled back [35].
Future research should provide evidence on how to
safely reduce the frequency of testing, what to do with
slightly abnormal test results (and associate risks of pa-
tient outcomes) and identify minimal testing sets.
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